| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.02 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |